GRCE vs PYPL · $35.0M cap vs P/E 7.9, rev $33.17B
Grace Therapeutics, Inc. (GRCE) versus PayPal Holdings Inc (PYPL) — a side-by-side from cached financials, not a winner call.
Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ. It is led by Alex Chriss.
GRCE does not have a complete income-statement cache yet.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
GRCE currently screens at market cap $35.0M. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Not investment advice. Open the GRCE and PYPL stock pages for the full models.
Not investment advice.